Scarica l'app Stockscreener
34.86
1.81%
0.62
Dopo l'orario di chiusura:
34.86
Newamsterdam Pharma Company Nv Borsa (NAMS) Ultime notizie
Momentum Shift: Should I trade or invest in NewAmsterdam Pharma Company NV2025 Support & Resistance & Reliable Momentum Entry Alerts - baoquankhu1.vn
Breakouts Watch: Will NewAmsterdam Pharma Company NV benefit from sector rotationBond Market & Fast Gain Stock Tips - baoquankhu1.vn
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Keybank National Association OH Acquires New Stake in NewAmsterdam Pharma Company N.V. $NAMS - Defense World
NewAmsterdam Pharma to Present at the Guggenheim Emerging Outlook: Biotech Summit - The Manila Times
Understanding Momentum Shifts in (NAMS) - Stock Traders Daily
NewAmsterdam Pharma (NAMS) Stock Analysis: Healthcare Innovator with 54% Potential Upside - DirectorsTalk Interviews
Published on: 2026-02-02 19:49:09 - baoquankhu1.vn
Aug Highlights: Should I trade or invest in NewAmsterdam Pharma Company NV2025 Breakouts & Breakdowns & Stepwise Swing Trade Plans - baoquankhu1.vn
Atle Fund Management AB Purchases 36,402 Shares of NewAmsterdam Pharma Company N.V. $NAMS - MarketBeat
Louise Frederika Kooij Sells 39,816 Shares of NewAmsterdam Pharma (NASDAQ:NAMS) Stock - Defense World
Buyback Watch: What are the risks of holding NewAmsterdam Pharma Company NV Equity WarrantJuly 2025 WrapUp & Weekly High Momentum Picks - baoquankhu1.vn
Take Profit: Can NewAmsterdam Pharma Company NV benefit from deglobalizationJuly 2025 Selloffs & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
NewAmsterdam Pharma (NASDAQ:NAMS) CAO Louise Frederika Kooij Sells 39,816 Shares of Stock - MarketBeat
NewAmsterdam Pharma (NASDAQ:NAMS) CAO Sells $1,037,061.60 in Stock - MarketBeat
Will NewAmsterdam Pharma Company N.V. stock recover after earningsWeekly Trade Report & Capital Protection Trading Alerts - mfd.ru
(NAMSW) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Is NewAmsterdam Pharma Company N.V.’s ROIC above industry averageEarnings Growth Summary & Step-by-Step Swing Trade Plans - mfd.ru
NewAmsterdam Pharma (NASDAQ:NAMS) CAO Louise Frederika Kooij Sells 38,172 Shares of Stock - MarketBeat
NewAmsterdam Pharma (NAMS) Stock Analysis: A Biotech Gem With 52% Upside Potential - DirectorsTalk Interviews
Bond Watch: Is ACOG a good ESG investment2025 Market Sentiment & Community Consensus Stock Picks - baoquankhu1.vn
Quarterly Recap: Is ESLT benefiting from innovation trendsTake Profit & Weekly Top Stock Performers List - baoquankhu1.vn
NewAmsterdam Pharma Company N.V. $NAMS Shares Acquired by Jennison Associates LLC - MarketBeat
Avoiding Lag: Real-Time Signals in (NAMS) Movement - Stock Traders Daily
Stock Recap: Will NewAmsterdam Pharma Company NV Equity Warrant benefit from AI trendsMarket Risk Analysis & Fast Moving Stock Trade Plans - baoquankhu1.vn
Update Report: Will NewAmsterdam Pharma Company NV Equity Warrant benefit from AI trends2025 Market WrapUp & Free Weekly Watchlist of Top Performers - baoquankhu1.vn
Assessing NewAmsterdam Pharma Co: Insights From 5 Financial Analysts - Benzinga
NewAmsterdam Pharma (NAMS) Stock Analysis: Evaluating The 52.72% Potential Upside - DirectorsTalk Interviews
Risks Report: Does HONDW stock have upside surprise potentialEarnings Overview Summary & Accurate Buy Signal Alerts - baoquankhu1.vn
Responsive Playbooks and the NAMSW Inflection - Stock Traders Daily
Aug Intraday: Will NewAmsterdam Pharma Company NV benefit from seasonalityJuly 2025 Price Swings & Daily Momentum Trading Reports - baoquankhu1.vn
Fed Meeting: Is NewAmsterdam Pharma Company NV Equity Warrant exposed to political riskPortfolio Return Summary & Daily Oversold Bounce Ideas - baoquankhu1.vn
Gains Report: What is the implied volatility of Drugs Made In America Acquisition Corp Equity RightWeekly Trade Analysis & AI Enhanced Execution Alerts - baoquankhu1.vn
Exit Recap: Is NewAmsterdam Pharma Company NV Equity Warrant exposed to political riskBear Alert & AI Enhanced Trading Alerts - baoquankhu1.vn
First Week of March 20th Options Trading For NewAmsterdam Pharma (NAMS) - Nasdaq
Relative Strength Alert For NewAmsterdam Pharma Company - Nasdaq
Aug Action: Does NewAmsterdam Pharma Company NV Equity Warrant align with a passive investing strategy2025 Historical Comparison & Precise Entry and Exit Recommendations - baoquankhu1.vn
Assessing NewAmsterdam Pharma (NAMS) Valuation After Recent Share Price Volatility - Yahoo Finance
Aug Rallies: How NewAmsterdam Pharma Company NV stock compares to market leadersPortfolio Update Summary & High Return Trade Guides - Bộ Nội Vụ
NewAmsterdam Pharma (NAMS) Stock Analysis: A Biotech With 46% Upside Potential - DirectorsTalk Interviews
Discipline and Rules-Based Execution in NAMS Response - Stock Traders Daily
NewAmsterdam Pharma (NASDAQ:NAMS) Trading Down 6.5%Time to Sell? - MarketBeat
NewAmsterdam expects EMA decision on cholesterol drug in second half 2026 - Investing.com Australia
NewAmsterdam Pharma outlines 2026 goals after strong 2025 progress - TipRanks
NewAmsterdam expects EMA decision on cholesterol drug in second half 2026 By Investing.com - Investing.com South Africa
NewAmsterdam Pharma Updates on Obicetrapib Clinical Development and EMA Approval Timeline - Quiver Quantitative
Drug in late-stage tests cuts cholesterol and an Alzheimer’s marker - Stock Titan
Can NewAmsterdam Pharma Company N.V. stock continue upward trendModel Comparison & how to pick the right width - Улправда
Why NewAmsterdam Pharma Company N.V. Equity Warrant stock attracts high net worth investorsJuly 2025 Selloffs & Reliable Volume Spike Alerts - ulpravda.ru
Can NewAmsterdam Pharma Company N.V. (KH6) stock hold up in economic slowdownMarket Activity Summary & AI Forecasted Entry and Exit Points - Улправда
Is NewAmsterdam Pharma Company N.V. Equity Warrant stock near bottom after declineAnalyst Upgrade & Verified Chart Pattern Signals - ulpravda.ru
Will NewAmsterdam Pharma Company N.V. Equity Warrant stock gain from strong economy2025 Historical Comparison & Community Consensus Stock Picks - Улправда
What dividend safety score for NewAmsterdam Pharma Company N.V. stock2025 Technical Patterns & Low Risk High Reward Ideas - Улправда
1.24%
0.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):